ask="1.80"
ask_size="1000"
average_daily_volume="328260"
bid="1.50"
bid_size="1000"
book_value="0.34"
change="-0.07"
change_from_200_day_moving_average="-0.20"
change_from_50_day_moving_average="-0.12"
change_from_52_week_high="-3.58"
change_From_52_week_low="0.41"
change_in_percent="-4.40%"
close="1.52"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="3761000"
high="1.65"
high_52_weeks="5.10"
last_trade_date="2/6/2017"
last_trade_price="1.52"
last_trade_size="900"
last_trade_time="4:00pm"
low="1.52"
low_52_weeks="1.11"
market_capitalization="14.57M"
moving_average_200_day="1.72"
moving_average_50_day="1.64"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.60"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-11.46%"
percent_change_from_50_day_moving_average="-7.31%"
percent_change_from_52_week_high="-70.20%"
percent_change_from_52_week_low="+36.94%"
previous_close="1.59"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.69"
price_per_sales="29.95"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="2.32"
stock_exchange="NCM"
symbol="EYEG"
volume="100439"
weeks_range_52="1.11 - 5.10"
